Coalition of Doctors Condemn FDA Decision to Deny Women Access to Bioidentical Hormones.
A coalition of gynecologists, internists, allergists, ER physicians and general practitioners responsible for treating thousands of women today criticized the Food and Drug Administration (FDA) for taking action that threatens to deny hundreds of thousands of women access to customized medications they take for symptoms of menopause. There are no legitimate medical, scientific or legal reasons for the FDA to take this action.
(PRWEB) January 14, 2008 -- A coalition of gynecologists, internists, allergists, ER physicians and general practitioners responsible for treating thousands of women today criticized the Food and Drug Administration (FDA) for taking action that threatens to deny hundreds of thousands of women access to customized medications they take for symptoms of menopause.
The FDA last week announced that the hormone estriol can no longer be used in estrogen medications customized for women by compounding pharmacies. Estriol is a component of 90 percent or more of these customized preparations. The FDA action is in response to a "citizen petition" filed by the giant drug maker Wyeth Pharmaceuticals. Wyeth is the maker of Premarin and Prempro, two hormone treatments for women that have been linked to cancer, heart disease and stroke by a 2002 Women's Health Initiative, National Institute of Health (NIH) study. Millions of women have discontinued taking Wyeth's hormone products as a result of the WHI study, which was halted because of the serious health risks that were discovered in 2002. For more: http://www.prweb.com/releases/BHI/FDA/prweb623221.htm
Posted by Louisville, Kentucky lawyer: Larry Jones 1-888-KYLAW22
